ArticleFrontiers in immunology2023

Bendamustine impairs humoral but not cellular immunity to SARS-CoV-2 vaccination in rituximab-treated B-cell lymphoma-affected patients.

Anna Vanni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.